Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

These weight loss medications, administered via injections, work by mimicking a hormone called GLP-1, which helps regulate appetite and blood sugar levels.

The promise of help with weight loss is always alluring. But what if that solution comes with a few hidden risks? In South Africa, where obesity rates are on the rise, GLP1 medications such ...

Eli Lilly posts robust Q4 earnings as Mounjaro and Zepbound sales more than double, lifting full-year revenue by 32% ...

"I would argue that GLP-1 for dietitians is the biggest tailwind that any single provider type in American health care has ...

The launch of UpSpring Stomach Settle Drops is causing an uproar as this revolutionary product is reversing the GLP1 side ...

It was a dose-ranging study, and the range of weight loss seen with Lilly’s drug was 9.4% to 14.7% at ... 46 weeks of treatment with their dual glucagon/GLP1 agonist survodutide (BI 456906 ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

Led by an interest in GLP-1 weight loss drugs, more health care brands may advertise in the Super Bowl this year.